Fungi

Red Light Holland Files New Patent: Technology and Devices for Monitoring Information and Influencing Behavior Involving Carbon Dioxide Emissions

Wednesday, July 21, 2021 - 2:13pm

Katie Patrick, Environmental Engineer, Author & Influencer Joins Red Light Holland team to Assist on Final Build Out of Wisdom, Designed by Karim Rashid, A Patent Pending "Smart Light" Aiding in Meditation and Displaying Your City's Carbon Emissions in Real-Time

Key Points: 
  • The Wisdom Truffle technology is developed by RadixMotion, a Silicon Valley based applied sciences wholly-owned subsidiary of Red Light Holland.
  • Each electric grid produces a dramatically varying amount of CO2 emissions at different times of the day, generally peaking in the early evening.
  • By utilizing the Wisdom Truffle's internet connectivity, along with its ability to change colours and patterns, Wisdom Truffle will be able to give real-time, localized information on active CO2 emissions.
  • "Reducing our carbon footprint is part of the psychedelic culture of healing and caring," said Sarah Hashkes CITO of Red Light Holland and CEO of RadixMotion.

Pure Extracts Submits Natural Health Product Licence Application for Class 3 Lion’s Mane Functional Mushroom Product

Thursday, July 22, 2021 - 1:50pm

A Lions Mane Class 3 licence would augment the Companys existing Class 1 licence granted by Health Canada on April 7, 2021 and would allow the Company to include cognitive health benefits in the products description.

Key Points: 
  • A Lions Mane Class 3 licence would augment the Companys existing Class 1 licence granted by Health Canada on April 7, 2021 and would allow the Company to include cognitive health benefits in the products description.
  • This Lions Mane product, when licensed, would be available for sale on the Companys Amazon online e-Commerce store, complimenting the current portfolio consisting of reishi and maitake functional wellness products.
  • The initial Class 1 Lions Mane product launch is expected to occur in Q4 2021 along with the Companys new blended mushroom product, with the Class 3 Lions Mane product launch expected to occur in Q1 2022.
  • Pure Extracts CEO, Ben Nikolaevsky, remarked, We are excited to be creating more Pure Mushrooms products for our direct-to-consumer, online store.

VidaCap Launches First Range of Adaptogenic Mushroom Blends in Capsule Form

Thursday, July 22, 2021 - 11:00am

However, it is unclear to what extent the active compounds in raw mushrooms are bioavailable (i.e.

Key Points: 
  • However, it is unclear to what extent the active compounds in raw mushrooms are bioavailable (i.e.
  • In capsule form, however, VidaCap suggests that active fungi compounds - compounds like polysaccharides, terpenes, and phenolics - are more readily "accessible" to the body.
  • "People across the world have been using these different types of fungi for millenia," says VidaCap co-founder Jeff Yauck.
  • VidaCap mushroom capsules are available for order now online via the company's official website, www.VidaCap.com .

Angel Yeast Unveils New Purpose-Built Yeast and Biotechnology R&D Center

Tuesday, July 13, 2021 - 3:50pm

YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.

Key Points: 
  • YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.
  • After it is put into operation, Angel Yeast estimates that over $60 million will be allocated annually into scientific research, with the aim to transform the complex into a leading global yeast technology research platform and a world-class biotechnology product R&D center.
  • We believe this project will further accelerate the advancement of Angel Yeast's innovation system in major industries, including yeast and yeast derivatives, healthy ingredients and raw materials, nutrition and healthcare, and non-yeast related biotechnologies," said Xiong Tao, chairman of Angel Yeast.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.

Angel Yeast Unveils New Purpose-Built Yeast and Biotechnology R&D Center

Tuesday, July 13, 2021 - 3:50pm

YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.

Key Points: 
  • YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.
  • Unveiled in June, the complex marks a major milestone for the group's scientific research process, as Angel Yeast continues to support the technological advancement of the biotechnology industry.
  • Since its inception, Angel Yeast has remained committed to scientific and technological progress, and is leading or participating in the formulation of all national and industry standards for yeast and yeast derivatives.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.

Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs to Six More Smart Shops

Tuesday, July 13, 2021 - 1:26pm

Significant increase in number of points of sale for iMicrodose Packs now in 30 Smart Shops (including Brick and Mortar stores and online shops) plus (approximately) 350,000 grams of packaged magic truffles sold from the Red Light Holland Farm in Horst, the Netherlands

Key Points: 
  • "Red Light Holland is doing incredible work in the Netherlands.
  • iMicrodose Packs powered by Red Light Holland are now available in 6 more locations than previously announced and we have sold approximately 350,000 grams of our magic truffles from the Red Light Holland Farm."
  • said Todd Shapiro, CEO and Director of Red Light Holland.
  • "The Red Light Holland Farm in Horst is running smoothly, as we continuously harvest from our 1,000,000 gram grow, with future sales expected imminently.

Truffle Capital Announces the Results of the 16th Truffle 100 Ranking

Thursday, July 8, 2021 - 7:00am

Created by the private equity firm Truffle Capital and the research and consulting firm teknowlogy | CXP-PAC, the Truffle 100 2021 provides an overview of the French software industry by analyzing the activity of the top 100 companies in the sector during 2020.

Key Points: 
  • Created by the private equity firm Truffle Capital and the research and consulting firm teknowlogy | CXP-PAC, the Truffle 100 2021 provides an overview of the French software industry by analyzing the activity of the top 100 companies in the sector during 2020.
  • This new trend, driven by the crisis, recorded a growth of +16 pts compared to the ranking published in 2020.
  • The 16th edition of the Truffle 100 is available on the following website: https://www.truffle100.fr/
    Founded in 2001, Truffle Capital is an independent European venture capital company, specializing in life sciences (MedTech and Biotech) and breakthrough technologies in the IT sectors (FinTech and InsurTech).
  • In 2019, Truffle Capital announced it had raised nearly 400 million in new institutional funds, including 140 million in Fintech/Insurtech.

Allied Corp Signs Psilocybin Manufacturing Agreement To Produce Psilonex™ RX For What We Believe To Be The Largest Known Psilocybin Patient Cohort In The World

Tuesday, June 29, 2021 - 1:00pm

Allied will be caring for these patients under physician supervision and seeking Section 56 special access exemptions for the Allied patients in order to receive Psilonex RX products.

Key Points: 
  • Allied will be caring for these patients under physician supervision and seeking Section 56 special access exemptions for the Allied patients in order to receive Psilonex RX products.
  • Research and development will continue and data will be gathered to further provide foundation for future research and product development.
  • Psilonex RX is a proprietary formulation of psilocybin, cordyceps, lions mane, vitamin B and other ingredients.
  • We have the patient cohort, the physician over-sight, the holistic nutritionists and psilocybin experts, the pharmacist scientists and physician research team all in place.

MCOA Subsidiary cDistro Signs Distribution Agreement with Silo Wellness and Marley One Functional Mushrooms 

Tuesday, June 29, 2021 - 1:00pm

Silo Wellness, a leading global psychedelics company, chosecDistro as one of its first distributors to launch Marley One, the first global functional and psychedelic mushroom consumer brand.

Key Points: 
  • Silo Wellness, a leading global psychedelics company, chosecDistro as one of its first distributors to launch Marley One, the first global functional and psychedelic mushroom consumer brand.
  • Silo has also announced that it intends to launch a psychedelic mushroom product line under the Marley name later this year, to be followed by additional functional mushroom products including gummies, capsules and cosmetics.
  • TheMarley family name is an iconic part of our history and were thrilled tobringthese exciting new products into our fast growing distribution portfolio.
  • We have already commenced our marketing efforts tointroduce and distribute Marley One, in collaboration withSilo Wellness and theBob Marley Family.

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species

Thursday, June 24, 2021 - 1:00pm

"At Numinus, one of the key goals of our lab's research and discovery work is to support accessibility to psychedelic-assisted psychotherapies," said Sharan Sidhu, Numinus Bioscience General Manager and Science Officer.

Key Points: 
  • "At Numinus, one of the key goals of our lab's research and discovery work is to support accessibility to psychedelic-assisted psychotherapies," said Sharan Sidhu, Numinus Bioscience General Manager and Science Officer.
  • "The rapid production process announced today meets that goal by enhancing our ability to seamlessly formulate safe and effective products with consistent psychoactive properties at scale, with the regulatory confidence that comes with standardized products."
  • Numinus initially tested the production process to rapidly generate a Psilocybe species extract as 'proof of concept'.
  • Results revealed a highly efficient, scalable process that can be applied to other species of psychoactive fungi.